Practice question

Answer the question and get instant feedback.

HardNeurologyParkinson's Disease Psychosismrcgp aktmrcp part 1ukmlapaneprescribing safety assessment

A 78-year-old man with Parkinson's disease complains of distressing visual hallucinations. He is currently treated with co-careldopa. His motor symptoms are otherwise reasonably controlled. What is the most appropriate next pharmacological step to manage his hallucinations according to NICE guidelines?

Educational content. Not a substitute for clinical judgement or local policy.